MIR logo

Mirion Technologies Stock Price

Symbol: NYSE:MIRMarket Cap: US$5.2bCategory: Tech

MIR Share Price Performance

US$22.70
12.88 (131.16%)
3.4% undervalued intrinsic discount
US$23.50
Fair Value
US$22.70
12.88 (131.16%)
3.4% undervalued intrinsic discount
US$23.50
Fair Value
Price US$22.70
AnalystConsensusTarget US$23.50

MIR Community Narratives

AnalystConsensusTarget·Updated
Fair Value US$23.50 3.4% undervalued intrinsic discount

Modernizing Nuclear Plants And SMR Advances Will Create Future Opportunities

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative

Recent MIR News & Updates

Mirion Technologies: Quiet Winner Of The Nuclear Upcycle

Sep 16

Here's Why Mirion Technologies (NYSE:MIR) Can Manage Its Debt Responsibly

Jul 17
Here's Why Mirion Technologies (NYSE:MIR) Can Manage Its Debt Responsibly

Mirion Technologies, Inc. Key Details

US$886.0m

Revenue

US$470.4m

Cost of Revenue

US$415.6m

Gross Profit

US$405.6m

Other Expenses

US$10.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.048
Gross Margin
46.91%
Net Profit Margin
1.13%
Debt/Equity Ratio
55.0%

Mirion Technologies, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Moderate growth potential with mediocre balance sheet.

2 Risks
3 Rewards

About MIR

Founded
2005
Employees
2860
CEO
Thomas Logan
WebsiteView website
www.mirion.com

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company’s products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Market Insight

The market has already priced in a 25bps rate cut from the Fed next week like it’s a done deal. So this week, we’re zooming in on what’s really been going on in the bond market, and what it all means for dividend investors who want to maintain yield.
Continue reading

U.S. Market Performance

  • 7 Days: 1.2%
  • 3 Months: 11.3%
  • 1 Year: 19.2%
  • Year to Date: 13.0%
The market has climbed 1.2% in the last 7 days, lead by the Consumer Discretionary sector with a gain of 4.6%. The market is up 19% over the last 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›